Collection of Czechoslovak Chemical Communications - digital archive 

Crossref Cited-by Linking

• Hrubaru Madalina-Marina, Draghici Constantin, Ngounoue Kamga Francis Aurelien, Diacu Elena, Egemonye ThankGod C., Ekennia Anthony C., Ungureanu Eleonora-Mihaela: Experiments and Calculation on New N,N-bis-Tetrahydroacridines. Molecules 2024, 29, 4082. <https://doi.org/10.3390/molecules29174082>
• Mahmoudi Masomeh, Saeidian Hamid, Mirjafary Zohreh, Mokhtari Javad: Controlled Release 7-Methoxytacrine-Polycaprolactone Nanocapsules Drug-Delivery System for Alzheimer's Disease Treatment: Synthesis and Physico-Chemical Characterization. J Polym Environ 2022, 30, 2280. <https://doi.org/10.1007/s10924-021-02349-2>
• Janockova Jana, Korabecny Jan, Plsikova Jana, Babkova Katerina, Konkolova Eva, Kucerova Dana, Vargova Jana, Koval Jan, Jendzelovsky Rastislav, Fedorocko Peter, Kasparkova Jana, Brabec Viktor, Rosocha Jan, Soukup Ondrej, Hamulakova Slavka, Kuca Kamil, Kozurkova Maria: In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers. Journal of Enzyme Inhibition and Medicinal Chemistry 2019, 34, 877. <https://doi.org/10.1080/14756366.2019.1593159>
• Benchekroun Mohamed, Romero Alejandro, Egea Javier, León Rafael, Michalska Patrycja, Buendía Izaskun, Jimeno María Luisa, Jun Daniel, Janockova Jana, Sepsova Vendula, Soukup Ondrej, Bautista-Aguilera Oscar M., Refouvelet Bernard, Ouari Olivier, Marco-Contelles José, Ismaili Lhassane: The Antioxidant Additive Approach for Alzheimer’s Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators. J. Med. Chem. 2016, 59, 9967. <https://doi.org/10.1021/acs.jmedchem.6b01178>
• Benchekroun Mohamed, Bartolini Manuela, Egea Javier, Romero Alejandro, Soriano Elena, Pudlo Marc, Luzet Vincent, Andrisano Vincenza, Jimeno María‐Luisa, López Manuela G., Wehle Sarah, Gharbi Tijani, Refouvelet Bernard, de Andrés Lucía, Herrera‐Arozamena Clara, Monti Barbara, Bolognesi Maria Laura, Rodríguez‐Franco María Isabel, Decker Michael, Marco‐Contelles José, Ismaili Lhassane: Novel Tacrine‐Grafted Ugi Adducts as Multipotent Anti‐Alzheimer Drugs: A Synthetic Renewal in Tacrine–Ferulic Acid Hybrids. ChemMedChem 2015, 10, 523. <https://doi.org/10.1002/cmdc.201402409>
• Spilovska Katarina, Korabecny Jan, Horova Anna, Musilek Kamil, Nepovimova Eugenie, Drtinova Lucie, Gazova Zuzana, Siposova Katarina, Dolezal Rafael, Jun Daniel, Kuca Kamil: Design, synthesis and in vitro testing of 7-methoxytacrine-amantadine analogues: a novel cholinesterase inhibitors for the treatment of Alzheimer’s disease. Med Chem Res 2015, 24, 2645. <https://doi.org/10.1007/s00044-015-1316-x>
• Spilovska Katarina, Korabecny Jan, Kral Jan, Horova Anna, Musilek Kamil, Soukup Ondrej, Drtinova Lucie, Gazova Zuzana, Siposova Katarina, Kuca Kamil: 7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies. Molecules 2013, 18, 2397. <https://doi.org/10.3390/molecules18022397>
• Korabecny Jan, Musilek Kamil, Zemek Filip, Horova Anna, Holas Ondrej, Nepovimova Eugenie, Opletalova Veronika, Hroudova Jana, Fisar Zdenek, Jung Young-Sik, Kuca Kamil: Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine—new tacrine derivate with cholinergic properties. Bioorganic & Medicinal Chemistry Letters 2011, 21, 6563. <https://doi.org/10.1016/j.bmcl.2011.08.042>
• Korabecny Jan, Musilek Kamil, Holas Ondrej, Binder Jiri, Zemek Filip, Marek Jan, Pohanka Miroslav, Opletalova Veronika, Dohnal Vlastimil, Kuca Kamil: Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease. Bioorganic & Medicinal Chemistry Letters 2010, 20, 6093. <https://doi.org/10.1016/j.bmcl.2010.08.044>
• Patočka Jiří, Jun Daniel, Kuča Kamil: In vitro Inactivation of Rat Brain Acetylcholinesterase by DSP-4 and Its Derivatives OS-21 and OS-23 and Protective Activity of Tacrine (9-Amino-1,2,3,4-tetrahydroacridine). Acta Med. (Hradec Kralove, Czech Repub.) 2005, 48, 145. <https://doi.org/10.14712/18059694.2018.42>
• Vargas M.G, Havel J, Patočka J: Capillary zone electrophoretic determination of some drugs against Alzheimer's disease. Journal of Chromatography A 1998, 802, 121. <https://doi.org/10.1016/S0021-9673(97)01117-5>
• Del Giudice Maria Rosaria, Borioni Anna, Mustazza Carlo, Gatta Franco: Synthesis of 9‐amino‐, 9‐aminomethyl‐1,2,3,4‐tetrahydro‐ and 1,2,3,4,5,6,7,8‐octahydroacridine derivatives. Journal of Heterocyclic Chem 1997, 34, 1661. <https://doi.org/10.1002/jhet.5570340604>
• Shvekhgeimer M. -G. A.: Synthesis of heterocyclic compounds by the cyclization of isatin and its derivatives (review). Chem Heterocycl Compd 1996, 32, 249. <https://doi.org/10.1007/BF01169241>
• Chaki Haruyuki, Yamabe Haruko, Sugano Mamoru, Morita Shuji, Bessho Tomoko, Tabata Reiko, Saito Ken-Ichi, Egawa Mitsuo, Tobe Akihiro, Morinaka Yasuhiro: Design and syntheses of 4-acylaminopyridine derivatives: Novel high affinity choline uptake enhancers II. Bioorganic & Medicinal Chemistry Letters 1995, 5, 1495. <https://doi.org/10.1016/0960-894X(95)00242-L>
• Nishioka Kazuhiko, Kamada Takeshi, Kanamaru Hiroshi: 14C‐labeling of a tetrahydroacridine, a novel CNS‐selective cholinesterase inhibitor. Labelled Comp Radiopharmac 1992, 31, 553. <https://doi.org/10.1002/jlcr.2580310707>
• Goncharenko S. B., Kaganskii M. M., Portnov Yu. N., Granik V. G.: Ionization constants of the drugs amiridin and tacrine and their analogs. Pharm Chem J 1992, 26, 769. <https://doi.org/10.1007/BF00770632>
• Patočka J., Bajgar J.: Aluminium activation and inhibition of human brain acetylcholinesterase in vitro. Inorganica Chimica Acta 1987, 135, 161. <https://doi.org/10.1016/S0020-1693(00)83282-X>
• BIELAVSKY J.: ChemInform Abstract: ANALOGS OF 9‐AMINO‐1,2,3,4‐TETRAHYDROACRIDINE. Chemischer Informationsdienst 1977, 8. <https://doi.org/10.1002/chin.197750245>